Skip to main content

Table 4 Annual percentage point changes in prevalence of antimicrobial resistant E. coli from bacteriuria episodes, 2014–2020

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

  Annual percent point change (95% CI)
  NIT T/S CIP ESBL Any AMR MDR
Community onset 0.34 (0.16, 0.51) 0.64 (0.04, 1.23) 0.13 (− 0.37, 0.62) 0.91 (0.56, 1.26) 1.00 (0.40, 1.61) 0.25 (− 0.21, 0.72)
Healthcare onset/associated 1.61 (0.74, 2.47) 0.41 (− 1.07, 1.90) − 0.59 (− 2.05, 0.87) 2.31 (1.01, 3.62) − 0.18 (− 1.54, 1.18) − 0.13 (− 1.52, 1.27)
  1. Data from a public healthcare system; CI: confidence interval, NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance. Logistic regression are univariate analyses including presence or absence of antimicrobial resistance to antibiotic and year from baseline